(Translation) 1/4 November 16, 2020 Re: Clarification of the operating results of company and its subsidiaries for the nine months period end September 30, 2020 To: President The Stock Exchange of
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
(Ending September 30, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial for Q3
No. ADD-IR2021/001 19 May 2021 Subject: Management discussion and analysis for the performance for the three-month period ended 31 March 2021 To: President The Stock Exchange of Thailand AddTech Hub
According to a case referral from the Stock Exchange of Thailand (SET), it was revealed that TRC executives had known or possessed inside information, as expressed in the auditor’s opinion, about TRC
Following a referral from the Stock Exchange of Thailand (SET) in 2023 and the SEC’s further investigation, the findings and evidence indicated that during 3 – 14 November 2022, before the inside
Special Investigation (DSI) for manipulating prices of 12 securities during 2008-2010.With referral from the Stock Exchange of Thailand on irregular trading condition of 12 securities, the SEC probed into
obligation: 24 January 2020 2.1 (X) Acquisition ( ) Disposition ( ) Through the Stock Exchange of Thailand via a securities company: Thai Securities company Foreign Securities company Big lot (please specify
obligation: 27 October 2020 2.1 (√ ) Acquisition ( ) Disposition ( ) Through the Stock Exchange of Thailand via a securities company: Thai Securities company Foreign Securities company Big lot (please specify
obligation: 30 October 2020 2.1 (✔) Acquisition ( ) Disposition ( ) Through the Stock Exchange of Thailand via a securities company: Thai Securities company Foreign Securities company Big lot (please specify